Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry Miguel MartínEva CarrascoDavid Aguiar-Bujanda Review Open access 20 June 2023 Pages: 151 - 159
Discordance of PIK3CA mutational status between primary and metastatic breast cancer: a systematic review and meta-analysis Justus RosinElla SvegrupIoannis Zerdes Review Open access 01 July 2023 Pages: 161 - 169
Molecular features of androgen-receptor low, estrogen receptor-negative breast cancers in the Carolina breast cancer study Nikita D. JinnaSarah Van AlstenMelissa A. Troester Preclinical study Open access 12 July 2023 Pages: 171 - 181
The prognostic and predictive role of tumor-infiltrating lymphocytes (FoxP3 + and CD8 +) and tumor-associated macrophages in early HER2 + breast cancer Minna M. JääskeläinenSatu TiainenPäivi Auvinen Preclinical study Open access 10 July 2023 Pages: 183 - 192
Randomized phase III trial of a neoadjuvant regimen of four cycles of adriamycin plus cyclophosphamide followed by four cycles of docetaxel (AC4-D4) versus a shorter treatment of three cycles of FEC followed by three cycles of docetaxel (FEC3-D3) in node-positive breast cancer (Neo-shorter; NCT02001506) Inhwan HwangJeong Eun KimSung-Bae Kim Clinical trial Open access 26 June 2023 Pages: 193 - 204
Preventative therapy for breast cancer: a clinical experience Rebekah LawKatherine KrupaJennifer Rusby Clinical trial Open access 19 June 2023 Pages: 205 - 213
Trends in use of neoadjuvant systemic therapy in patients with clinically node-positive breast cancer in Europe: prospective TAXIS study (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101) Christoph TauschKavitha DästerWalter Paul Weber Clinical trial Open access 25 June 2023 Pages: 215 - 225
Pathologic complete response of ductal carcinoma in situ to neoadjuvant systemic therapy in HER2-positive invasive breast cancer patients: a nationwide analysis Roxanne A. W. PloumenEva L. ClaassensMarjolein L. Smidt Clinical trial Open access 03 July 2023 Pages: 227 - 235
Evaluation of SNPs associated with mammographic density in European women with mammographic density in Asian women from South-East Asia Shivaani MariapunWeang Kee HoSoo-Hwang Teo Epidemiology 20 June 2023 Pages: 237 - 245
Comparing quality of breast cancer care in the Netherlands and Norway by federated propensity score analytics Dave T. HamersmaKay SchreuderSabine Siesling Epidemiology Open access 25 June 2023 Pages: 247 - 256
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation Joanne KotsopoulosJacek Gronwaldand the Hereditary Breast Cancer Clinical Study Group Epidemiology 11 July 2023 Pages: 257 - 264
Real-world data analysis of perioperative chemotherapy patterns, G-CSF use, and FN status in patients with early breast cancer Nobuhiro ShibataTetsuhiro YoshinamiShinji Ohno Epidemiology Open access 06 July 2023 Pages: 265 - 273
Racial disparities in treatment and outcomes between non-Hispanic Black and non-Hispanic White women with nonmetastatic inflammatory breast cancer Walter H. Carbajal-OchoaDevin JohnsonJesus D. Anampa Epidemiology 13 July 2023 Pages: 275 - 287
Intratumor spatial heterogeneity in programmed death-ligand 1 (PD-L1) protein expression in early-stage breast cancer Adriana Matutino KahnReza GolestaniLajos Pusztai Brief Communication 28 June 2023 Pages: 289 - 298
Quantifying radiation in the axillary bed at the site of lymphedema surgical prevention Rosie FriedmanDaphna Y. SpiegelDhruv Singhal Original Laboratory Investigation 29 June 2023 Pages: 299 - 305
Investigating potential immune mechanisms of trilaciclib administered prior to chemotherapy in patients with metastatic triple-negative breast cancer Antoinette R. TanJoyce O’ShaughnessyJohn S. Yi Original Laboratory Investigation Open access 07 July 2023 Pages: 307 - 316
HSD17B4 methylation enhances glucose dependence of BT-474 breast cancer cells and increases lapatinib sensitivity Nobuaki AraiNaoko HattoriToshikazu Ushijima Original Laboratory Investigation 28 June 2023 Pages: 317 - 328
Subtypes of high-grade breast ductal carcinoma in situ (DCIS): incidence and potential clinical impact Hossein SchandizDaehoon ParkTorill Sauer Original Laboratory Investigation Open access 15 July 2023 Pages: 329 - 338
S100A8 gene copy number and protein expression in breast cancer: associations with proliferation, histopathological grade and molecular subtypes Mathieu Le Boulvais BørkjaMiriam S. GiambellucaAnna M Bofin Original Laboratory Investigation Open access 14 July 2023 Pages: 339 - 350
Letter to the editor regarding “Association between gout and subsequent breast cancer: a retrospective cohort study including 67,598 primary care patients in Germany” Gang WangMei TangZhichun Liu Letter to the Editor 10 July 2023 Pages: 351 - 352
